• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists.

作者信息

Robin E D, McCauley R

机构信息

Tsurai Indian Health Care Clinic, Trinidad, California.

出版信息

Chest. 1992 Jun;101(6):1699-702. doi: 10.1378/chest.101.6.1699.

DOI:10.1378/chest.101.6.1699
PMID:1350972
Abstract
摘要

相似文献

1
Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists.
Chest. 1992 Jun;101(6):1699-702. doi: 10.1378/chest.101.6.1699.
2
Infrequent cardiac deaths occur in bronchial asthma.支气管哮喘患者中偶有心脏性死亡发生。
Chest. 1992 Jun;101(6):1703-5. doi: 10.1378/chest.101.6.1703.
3
Present state of the controversy about regular inhaled beta-agonists in asthma.
Eur Respir J. 1995 May;8(5):673-8.
4
Beta-agonists and death from asthma.
N Engl J Med. 1992 Jul 30;327(5):355-7.
5
Inhaled beta-agonist use and life-threatening asthma.
Am J Respir Crit Care Med. 1995 Jul;152(1):414. doi: 10.1164/ajrccm.152.1.7599860.
6
Bronchodilators and acute cardiac death.支气管扩张剂与急性心源性死亡
Am J Respir Crit Care Med. 1997 Jul;156(1):333.
7
Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthma.
Respir Med. 1992 Nov;86(6):471-6. doi: 10.1016/s0954-6111(96)80004-7.
8
Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.哮喘治疗中吸入性β2肾上腺素能激动剂：不断演变的困境
Singapore Med J. 1994 Jun;35(3):237-9.
9
Inhaled beta 2-adrenergic agonists in asthma. The Executive Committee of the American Academy of Allergy and Immunology.哮喘中吸入性β2肾上腺素能激动剂。美国过敏与免疫学会执行委员会。
J Allergy Clin Immunol. 1993 Jun;91(6):1234-7.
10
[Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].[哮喘治疗中β2激动剂的剂量应重新评估]
Lakartidningen. 1991 Oct 30;88(44):3643-5.

引用本文的文献

1
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences.哮喘与心血管疾病：共同药物相互作用的应对策略。
Drugs. 2024 Oct;84(10):1251-1273. doi: 10.1007/s40265-024-02086-5. Epub 2024 Sep 26.
2
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD：聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
3
Evaluation of the Early Effects of Childhood Asthma and Its Treatment on Cardiac Function as Revealed by Two-Dimensional Speckle-Tracking Echocardiography.
二维斑点追踪超声心动图评价儿童哮喘及其治疗对心功能的早期影响。
Pediatr Cardiol. 2024 Apr;45(4):858-866. doi: 10.1007/s00246-022-02941-w. Epub 2022 Aug 29.
4
Prominent Bronchopulmonary Vascular Anastomoses in Fatal Childhood Asthma.致命性儿童哮喘中显著的支气管肺血管吻合
Ann Am Thorac Soc. 2018 Nov;15(11):1359-1362. doi: 10.1513/AnnalsATS.201804-262RL.
5
The effects of treatment in patients with childhood asthma on the elastic properties of the aorta.儿童哮喘患者的治疗对主动脉弹性特性的影响。
Cardiovasc J Afr. 2017 May/Jun;28(3):165-169. doi: 10.5830/CVJA-2016-076.
6
Sudden cardiac death due to β2-agonist therapy: is a genetic basis overlooked?β2激动剂治疗导致的心源性猝死：遗传因素是否被忽视了？
Cardiovasc J Afr. 2012 Mar;23(2):97,102.
7
Cardiovascular morbidity and the use of inhaled bronchodilators.心血管疾病发病率与吸入性支气管扩张剂的使用
Int J Chron Obstruct Pulmon Dis. 2008;3(1):163-9. doi: 10.2147/copd.s1516.
8
Overcoming gaps in the management of asthma in older patients: new insights.克服老年患者哮喘管理中的差距：新见解
Drugs Aging. 2005;22(12):1029-59. doi: 10.2165/00002512-200522120-00004.
9
Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.β₂肾上腺素能受体激动剂用于阻塞性气道疾病患者的心血管安全性：一项系统评价。
Drugs Aging. 2004;21(6):405-14. doi: 10.2165/00002512-200421060-00005.
10
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.长效β2受体激动剂引发非致命性心力衰竭和缺血性心脏病的风险。
Thorax. 1998 Jul;53(7):558-62. doi: 10.1136/thx.53.7.558.